Probiotics for periodontal health-Current molecular findings

Trang Nguyen, Hanna Brody, Alan Radaic, Yvonne Kapila, Trang Nguyen, Hanna Brody, Alan Radaic, Yvonne Kapila

Abstract

Dysbiosis of the oral microbiome is associated with a variety of oral and systemic diseases, including periodontal disease. Oral dysbiosis in periodontal disease leads to an exacerbated host immune response that induces progressive periodontal tissue destruction and ultimately tooth loss. To counter the disease-associated dysbiosis of the oral cavity, strategies have been proposed to reestablish a "healthy" microbiome via the use of probiotics. This study reviews the literature on the use of probiotics for modifying the oral microbial composition toward a beneficial state that might alleviate disease progression. Four in vitro and 10 preclinical studies were included in the analysis, and these studies explored the effects of probiotics on cultured biofilm growth and bacterial gene expressions, as well as modulation of the host response to inflammation. The current molecular findings on probiotics provide fundamental evidence for further clinical research for the use of probiotics in periodontal therapy. They also point out an important caveat: Changing the biofilm composition might alter the normal oral flora that is beneficial and/or critical for oral health.

Keywords: in vitro; in vivo; periodontal; probiotics.

Conflict of interest statement

The authors report no conflicts of interest related to this study.

© 2021 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd.

References

    1. Tonetti MS, Jepsen S, Jin L, Otomo‐Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: a call for global action. J Clin Periodontol. 2017;44(5):456‐462.
    1. Chapple IL, Van der Weijden F, Doerfer C, et al. Primary prevention of periodontitis: managing gingivitis. J Clin Periodontol. 2015;42(Suppl 16):S71‐S76.
    1. Tonetti MS, Eickholz P, Loos BG, et al. Principles in prevention of periodontal diseases: consensus report of Group 1 of the 11th European Workshop on Periodontology on effective prevention of periodontal and peri‐implant diseases. J Clin Periodontol. 2015;42(Suppl 16):S5‐S11.
    1. Armitage GC. Clinical evaluation of periodontal diseases. Periodontol 2000. 1995;7:39‐53.
    1. Tonetti MS, Van Dyke TE, Working Group 1 of the Joint EFP/AAP Workshop . Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(Suppl 14):S24‐S29.
    1. Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology. J Clin Periodontol. 2018;45(2):138‐149.
    1. Eke PI, Wei L, Thornton‐Evans GO, et al. Risk indicators for periodontitis in US adults: NHANES 2009 to 2012. J Periodontol. 2016;87(10):1174‐1185.
    1. White DA, Tsakos G, Pitts NB, et al. Adult Dental Health Survey 2009: common oral health conditions and their impact on the population. Br Dent J. 2012;213(11):567‐572.
    1. Page RC. Gingivitis. J Clin Periodontol. 1986;13(5):345‐359.
    1. Sanz M, Beighton D, Curtis MA, et al. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of Group 1 of the Joint EFP/ORCA workshop on the boundaries between caries and periodontal disease. J Clin Periodontol. 2017;44(Suppl 18):S5‐S11.
    1. Cobb CM. Clinical significance of non‐surgical periodontal therapy: an evidence‐based perspective of scaling and root planing. J Clin Periodontol. 2002;29(Suppl 2):6‐16.
    1. Goodson JM, Haffajee AD, Socransky SS, et al. Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. J Clin Periodontol. 2012;39(6):526‐536.
    1. Claffey N, Polyzois I, Ziaka P. An overview of nonsurgical and surgical therapy. Periodontol 2000. 2004;36:35‐44.
    1. D'Aiuto F, Gkranias N, Bhowruth D, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single‐centre, investigator‐masked, randomised trial. Lancet Diabet Endocrinol. 2018;6(12):954‐965.
    1. Teeuw WJ, Slot DE, Susanto H, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta‐analysis. J Clin Periodontol. 2014;41(1):70‐79.
    1. Tomasi C, Leyland AH, Wennstrom JL. Factors influencing the outcome of non‐surgical periodontal treatment: a multilevel approach. J Clin Periodontol. 2007;34(8):682‐690.
    1. van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000. 1996;10:45‐78.
    1. Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dental Res J. 2012;9(5):505‐515.
    1. Teughels W, Van Essche M, Sliepen I, Quirynen M. Probiotics and oral healthcare. Periodontol 2000. 2008;48:111‐147.
    1. Food and Agriculture Organization of the United Nations/ World Health Organization FAO/ WHO . Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Liv Lactic Acid Bacteria. 2021. 2014.
    1. Bizzini B, Pizzo G, Scapagnini G, Nuzzo D, Vasto S. Probiotics and oral health. Curr Pharm Des. 2012;18(34):5522‐5531.
    1. Devine DA, Marsh PD. Prospects for the development of probiotics and prebiotics for oral applications. J Oral Microbiol. 2009;1: 3402.
    1. Zupancic S, Rijavec T, Lapanje A, Petelin M, Kristl J, Kocbek P. Nanofibers with incorporated autochthonous bacteria as potential probiotics for local treatment of periodontal disease. Biomacromolecules. 2018;19(11):4299‐4306.
    1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43(11):5721‐5732.
    1. Terai T, Okumura T, Imai S, et al. Screening of probiotic candidates in human oral bacteria for the prevention of dental disease. PLoS One. 2015;10(6):e0128657.
    1. Kõll‐Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol. 2005;20(6):354‐361.
    1. Hazards EPB, Ricci A, Allende A et al. Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 8: suitability of taxonomic units notified to EFSA until March 2018. EFSA J. 2018;16(7):e05315.
    1. Khalaf H, Nakka SS, Sanden C, et al. Antibacterial effects of Lactobacillus and bacteriocin PLNC8 αβ on the periodontal pathogen Porphyromonas gingivalis . BMC Microbiol. 2016;16(1):188.
    1. Zhu Y, Xiao L, Shen D, Hao Y. Competition between yogurt probiotics and periodontal pathogens in vitro. Acta Odontol Scand. 2010;68(5):261‐268.
    1. Parcina Amizic I, Cigic L, Gavic L, et al. Antimicrobial efficacy of probiotic‐containing toothpastes: an in vitro evaluation. Med Glas. 2017;14(1):139‐144. doi: 10.17392/870‐16. PMID: 28165440
    1. Fritschi BZ, Albert‐Kiszely A, Persson GR. Staphylococcus aureus and other bacteria in untreated periodontitis. J Dent Res. 2008;87(6):589‐593.
    1. Doran A, Kneist S, Verran J. Ecological control: in vitro inhibition of anaerobic bacteria by oral streptococci. Microbial Ecol Health Dis. 2004;16(1):23‐27.
    1. Cornacchione LP, Klein BA, Duncan MJ, Hu LT. Interspecies inhibition of Porphyromonas gingivalis by yogurt‐derived Lactobacillus delbrueckii requires active pyruvate oxidase. Appl Environ Microbiol. 2019;85(18):e01271‐19.
    1. Lorquet F, Goffin P, Muscariello L, et al. Characterization and functional analysis of the poxB gene, which encodes pyruvate oxidase in Lactobacillus plantarum . J Bacteriol. 2004;186(12):3749‐3759.
    1. Marty‐Teysset C, de la Torre F, Garel J. Increased production of hydrogen peroxide by Lactobacillus delbrueckii subsp. bulgaricus upon aeration: involvement of an NADH oxidase in oxidative stress. Appl Environ Microbiol. 2000;66(1):262‐267.
    1. Hertzberger R, Arents J, Dekker HL, et al. H2O2 production in species of the Lactobacillus acidophilus group: a central role for a novel NADH‐dependent flavin reductase. Appl Environ Microbiol. 2014;80(7):2229‐2239.
    1. Liu W, Pang H, Zhang H, Cai Y. Biodiversity of lactic acid bacteria. In: Zhang H, Cai Y, eds. Lactic Acid Bacteria: Fundamentals and Practice. Dordrecht, Netherlands: Springer; 2014:103‐203.
    1. Rea MC, Ross RP, Cotter PD, Hill C. Classification of bacteriocins from gram‐positive bacteria. In: Drider D, Rebuffat S, eds. Prokaryotic Antimicrobial Peptides: From Genes to Applications. New York, NY: Springer; 2011:29‐53.
    1. Masdea L, Kulik EM, Hauser‐Gerspach I, Ramseier AM, Filippi A, Waltimo T. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol. 2012;57(8):1041‐1047.
    1. Baca‐Castanon ML, De la Garza‐Ramos MA, Alcazar‐Pizana AG, et al. Antimicrobial effect of Lactobacillus reuteri on cariogenic bacteria Streptococcus gordonii, Streptococcus mutans, and periodontal diseases Actinomyces naeslundii and Tannerella forsythia . Probiotics Antimicrob Proteins. 2015;7(1):1‐8.
    1. Heeney DD, Zhai Z, Bendiks Z, et al. Lactobacillus plantarum bacteriocin is associated with intestinal and systemic improvements in diet‐induced obese mice and maintains epithelial barrier integrity in vitro. Gut Microbes. 2018;10:382‐397.
    1. Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. J Appl Microbiol. 2016;120(6):1449‐1465.
    1. Tong Z, Dong L, Zhou L, Tao R, Ni L. Nisin inhibits dental caries‐associated microorganism in vitro. Peptides. 2010;31(11):2003‐2008.
    1. Bartoloni A, Mantella A, Goldstein BP, et al. In‐vitro activity of nisin against clinical isolates of Clostridium difficile . J Chemother (Florence, Italy). 2004;16(2):119‐121.
    1. Shin JM, Ateia I, Paulus JR, et al. Antimicrobial nisin acts against saliva derived multi‐species biofilms without cytotoxicity to human oral cells. Front Microbiol. 2015;6:617.
    1. Piper C, Hill C, Cotter PD, Ross RP. Bioengineering of a Nisin A–producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z. Microb Biotechnol. 2011;4(3):375‐382.
    1. Slomka V, Herrero ER, Boon N, et al. Oral prebiotics and the influence of environmental conditions in vitro. J Periodontol. 2018;89(6):708‐717.
    1. Slomka V, Hernandez‐Sanabria E, Herrero ER, et al. Nutritional stimulation of commensal oral bacteria suppresses pathogens: the prebiotic concept. J Clin Periodontol. 2017;44(4):344‐352.
    1. Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. A review of the advancements in probiotic delivery: conventional vs. non‐conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2013;15(1):29‐43.
    1. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ Jr. Communication among oral bacteria. Microbiol Mol Biol Rev. 2002;66(3):486–505.
    1. Yadav AK, Tyagi A, Kumar A, et al. Adhesion of lactobacilli and their anti‐infectivity potential. Crit Rev Food Sci Nutr. 2017;57(10):2042‐2056.
    1. Albuquerque‐Souza E, Balzarini D, Ando‐Suguimoto ES, et al. Probiotics alter the immune response of gingival epithelial cells challenged by Porphyromonas gingivalis . J Periodont Res. 2019;54(2):115‐127.
    1. Zhao JJ, Feng XP, Zhang XL, Le KY. Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on secretion of IL1B, IL6, and IL8 by gingival epithelial cells. Inflammation. 2012;35(4):1330‐1337.
    1. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. Epithelial cell pro‐inflammatory cytokine response differs across dental plaque bacterial species. J Clin Periodontol. 2010;37(1):24‐29.
    1. Huang GT, Kim D, Lee JK, Kuramitsu HK, Haake SK. Interleukin‐8 and intercellular adhesion molecule 1 regulation in oral epithelial cells by selected periodontal bacteria: multiple effects of Porphyromonas gingivalis via antagonistic mechanisms. Infect Immun. 2001;69(3):1364‐1372.
    1. Gatej SM, Marino V, Bright R, et al. Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis. J Clin Periodontol. 2018;45(2):204‐212.
    1. Ricoldi MST, Furlaneto FAC, Oliveira LFF, et al. Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non‐surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats. PLoS One. 2017;12(6):e0179946.
    1. Oliveira LF, Salvador SL, Silva PH, et al. Benefits of Bifidobacterium animalis subsp. lactis probiotic in experimental periodontitis. J Periodontol. 2017;88(2):197‐208.
    1. Maekawa T, Hajishengallis G. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J Periodont Res. 2014;49(6):785‐791.
    1. Messora MR, Oliveira LFF, Foureaux RC, et al. Effects of probiotic therapy on metabolic and inflammatory parameters of rats with ligature‐induced periodontitis associated with restraint stress. J Periodontol. 2014;85(7):975‐983.
    1. Messora MR, Oliveira LFF, Foureaux RC, et al. Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature‐induced periodontitis. J Periodontol. 2013;84(12):1818‐1826.
    1. Garcia VG, Knoll LR, Longo M, et al. Effect of the probiotic Saccharomyces cerevisiae on ligature‐induced periodontitis in rats. J Periodont Res. 2016;51(1):26‐37.
    1. Nackaerts O, Jacobs R, Quirynen M, Rober M, Sun Y, Teughels W. Replacement therapy for periodontitis: pilot radiographic evaluation in a dog model. J Clin Periodontol. 2008;35(12):1048‐1052.
    1. Messora MR, Pereira LJ, Foureaux R, et al. Favourable effects of Bacillus subtilis and Bacillus licheniformis on experimental periodontitis in rats. Arch Oral Biol. 2016;66:108‐119.
    1. Chatterjee A, Bhattacharya H, Kandwal A. Probiotics in periodontal health and disease. J Indian Soc Periodontol. 2011;15(1):23‐28.
    1. Berezow AB, Darveau RP. Microbial shift and periodontitis. Periodontol 2000. 2011;55(1):36‐47.
    1. Park SY, Kim YH, Kim EK, Ryu EY, Lee SJ. Heme oxygenase‐1 signals are involved in preferential inhibition of pro‐inflammatory cytokine release by surfactin in cells activated with Porphyromonas gingivalis lipopolysaccharide. Chem Biol Interact. 2010;188(3):437‐445.
    1. Brunt J, Newaj‐Fyzul A, Austin B. The development of probiotics for the control of multiple bacterial diseases of rainbow trout, Oncorhynchus mykiss (Walbaum). J Fish Dis. 2007;30(10):573‐579.
    1. Newaj‐Fyzul A, Adesiyun AA, Mutani A, Ramsubhag A, Brunt J, Austin B. Bacillus subtilis AB1 controls Aeromonas infection in rainbow trout (Oncorhynchus mykiss, Walbaum). J Appl Microbiol. 2007;103(5):1699‐1706.
    1. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis. 2008;14(11):1585‐1596.
    1. Veerappan GR, Betteridge J, Young PE. Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep. 2012;14(4):324‐333.
    1. Di Marzio L, Russo FP, D'Alo S, et al. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer. 2001;40(2):185‐196.
    1. Herrera BS, Martins‐Porto R, Maia‐Dantas A, et al. iNOS‐derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature‐induced periodontitis in rats. J Periodontol. 2011;82(11):1608‐1615.
    1. Pan Z, Guzeldemir E, Toygar HU, Bal N, Bulut S. Nitric oxide synthase in gingival tissues of patients with chronic periodontitis and with and without diabetes. J Periodontol. 2010;81(1):109‐120.
    1. Kendall HK, Haase HR, Li H, Xiao Y, Bartold PM. Nitric oxide synthase type‐II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodont Res. 2000;35(4):194‐200.
    1. Leitao RF, Ribeiro RA, Chaves HV, Rocha FA, Lima V, Brito GA. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J Periodontol. 2005;76(6):956‐963.
    1. Gatej SM, Bright R, Weyrich LS, et al. Probiotic Lactobacillus rhamnosus GG protects against P. gingivalis and F. nucleatum gut dysbiosis. J Int Acad Periodontol. 2020;22(2):18‐27.
    1. Shao MY, Huang P, Cheng R, Hu T. Interleukin‐6 polymorphisms modify the risk of periodontitis: a systematic review and meta‐analysis. J Zhejiang Univ Sci B. 2009;10(12):920‐927.
    1. Waldner MJ, Neurath MF. Master regulator of intestinal disease: IL‐6 in chronic inflammation and cancer development. Semin Immunol. 2014;26(1):75‐79.
    1. Karumuthil‐Melethil S, Gudi R, Johnson BM, Perez N, Vasu C. Fungal β‐glucan, a Dectin‐1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response. J Immunol (Baltimore, Md: 1950). 2014;193(7):3308–3321.
    1. Wei D, Zhang L, Williams DL, Browder IW. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor‐1 dependent mechanism. Wound repair and regeneration. Wound Repair Regen. 2002;10(3):161‐168.
    1. Novak M, Vetvicka V. β‐Glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol. 2008;5(1):47‐57.
    1. Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T. Role of periodontal pathogenic bacteria in RANKL‐mediated bone destruction in periodontal disease. J Oral Microbiol. 2010;2:5532.
    1. Ma L, Ding Q, Feng X, Li F. The protective effect of recombinant FomA‐expressing Lactobacillus acidophilus against periodontal infection. Inflammation. 2013;36(5):1160‐1170.
    1. Bosch M, Rodriguez M, Garcia F, Fernández E, Fuentes M, Cuñé J. Probiotic properties of Lactobacillus plantarum CECT 7315 and CECT 7316 isolated from faeces of healthy children. Letters in Applied Microbiology. 2012;54:240‐246. 10.1111/j.1472-765X.2011.03199.x
    1. Chen LJ, Tsai HT, Chen WJ, et al. In vitro antagonistic growth effects of Lactobacillus fermentum and Lactobacillus salivarius and their fermentative broth on periodontal pathogens. Braz. J. Microbiol. 2012;43(4):1376‐1384.
    1. Saha LJ, Tomaro‐Duchesneau C, Daoud JT, Tabrizian M, Prakash S. Novel probiotic dissolvable carboxymethyl cellulose films as oral health biotherapeutics: in vitro preparation and characterization. Expert Opinion on Drug Delivery. 2013;10(11):1471‐1482. 10.1111/j.1472-765X.2011.03199.x
    1. Amižić IP, Cigić L, Gavić L, et al. Antimicrobial efficacy of probiotic‐containing toothpastes: an in vitro evaluation. Med. Glas. (Zenica). 2017;14(1):139‐144. 10.17392/870-16
    1. Yamada M, Takahashi N, Matsuda Y, et al. A bacterial metabolite ameliorates periodontal pathogen‐induced gingival epithelial barrier disruption via GPR40 signaling. Med. Glas. (Zenica). 2018;8:9008. 10.1038/s41598-018-27408-y
    1. Khasenbekova Z, Saduakhasova S, Gulayev A, et al. Effect of Probiotic consortium on the local inflammatory process in chronic periodontitis. Cent. Asian J. Glob. Health. 2014;2(Suppl):109. 10.5195/cajgh.2013.109

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit